#PaperoftheDay: "Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations" https://t.co/qqZJXNp9A4 #oncology #lungcancer #openaccess #research #medicine #medEd #OA
3,270 followers
622 followers
RT @Oncotarget: #PaperoftheDay: "Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptati…
3,270 followers
#PaperoftheDay: "Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations" https://t.co/qqZJXNpHpC #oncology #lungcancer #openaccess #research #medicine #medEd #OA
3,270 followers
#PaperoftheDay: "Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations" https://t.co/ZYmOkDg4kF #oncology #lungcancer #openaccess #research #medicine #medEd #OA